Pharmaceutical Analysis & Statistics, August 2014 (p40)

Talk to Clare

+1 339 368 6001

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

1171-1220 of about 24 000 reports

Purchase Reports From Reputable Market Research Publishers

Respiratory Partnering Terms and Agreements

Respiratory Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Respiratory Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the respiratory partnering deals and agreements entered into by the worlds leading ...

  • Industries : Pathology
Dental Partnering Terms and Agreements

Dental Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Dental Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the dental partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Pathology
Gastrointestinal Partnering Terms and Agreements

Gastrointestinal Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Gastrointestinal Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gastrointestinal partnering deals and agreements entered into by the worlds ...

  • Industries : Pathology
Genitourinary Partnering Terms and Agreements

Genitourinary Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Genitourinary Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the genitourinary partnering deals and agreements entered into by the worlds leading ...

  • Industries : Pathology
PCSK9 and Other Novel Hypercholesterolemia Drugs Market, 2014 - 2024

PCSK9 and Other Novel Hypercholesterolemia Drugs Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • September 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Worldwide statistics indicate that there is a high cholesterol burden despite the presence of many cholesterol-lowering drugs in the market. Out of all the available options, statins have ...

  • Industries : Drug and Medication
HPAPIs and Cytotoxic Drugs Manufacturing Market

HPAPIs and Cytotoxic Drugs Manufacturing Market

  • $ 1 899
  • Industry report
  • August 2014
  • by Roots Analysis Private Ltd.

The ‘HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014-2024' report provides an extensive study of the rapidly growing manufacturing market of HPAPIs and cytotoxic drugs. Due to their numerous advantages ...

  • Industries : Drug and Medication
Prefilled Syringes Market (2nd Edition), 2014-2024

Prefilled Syringes Market (2nd Edition), 2014-2024

  • $ 1 899
  • Industry report
  • July 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Prefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs. They have become a preferred device for parenteral administration of drugs, mainly ...

  • Industries : Drug Delivery Technology
  • Countries : China, World, Japan, United States, India
Pharmaceutical Spray Drying Market, 2014-2024

Pharmaceutical Spray Drying Market, 2014-2024

  • $ 1 899
  • Industry report
  • June 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION The concept of ‘spray drying' started in late 19th century in the food and chemical industry. Within pharmaceutical industry, spray drying found its use initially for the production of APIs. ...

  • Industries : Drug and Medication
  • Countries : India
Consumer Health Trends in Eastern Europe

Consumer Health Trends in Eastern Europe

  • $ 1 995
  • Industry report
  • June 2014
  • by Euromonitor International

Eastern Europe is one of the world's most intriguing consumer health regions. Anchored by the large Russian market, many are quick to overlook the myriad secondary markets that drive much of the region's ...

  • Industries : Vitamin and Supplement
  • Countries : Europe
Angiogenesis in Oncology Drug Pipeline Update 2014

Angiogenesis in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 305 companies plus partners developing 376 angiogenesis drugs in 1674 developmental projects in cancer. In addition, there are 9 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Drug Discovery and Development
Apoptosis in Oncology Drug Pipeline Update 2014

Apoptosis in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis ...

  • Industries : Drug Discovery and Development
Brain Cancer Drug Pipeline Update 2014

Brain Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases ...

  • Industries : Drug and Medication
Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

  • Industries : Drug and Medication
Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pipeline Update 2014

Colorectal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Drug and Medication
Head and Neck Cancer Drug Pipeline Update 2014

Head and Neck Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 144 companies plus partners developing 160 drugs targeting head and neck cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug and Medication
Leukemia Drug Pipeline Update 2014

Leukemia Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 292 companies plus partners developing 417 leukemia drugs in 632 developmental ...

  • Industries : Pathology
Lung Cancer Drug Pipeline Update 2014

Lung Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication
Lymphoma Drug Pipeline Update 2014

Lymphoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 249 companies plus partners developing 381 lymphoma drugs in 606 developmental projects in cancer. In ...

  • Industries : Pathology
Melanoma Drug Pipeline Update 2014

Melanoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients ...

  • Industries : Pathology
Ovarian Cancer Drug Pipeline Update 2014

Ovarian Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pipeline Update 2014

Pancreatic Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 272 companies plus partners developing 328 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ...

  • Industries : Drug and Medication
Peptides in Oncology Drug Pipeline Update 2014

Peptides in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 236 companies plus partners developing 232 peptide drugs in 587 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug Discovery and Development
Prostate Cancer Drug Pipeline Update 2014

Prostate Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various ...

  • Industries : Drug and Medication
Radiation Therapy in Oncology Drug Pipeline Update 2014

Radiation Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update is structured around radiolabeled drugs, radiosensitizers and radioprotective compounds. There are today 318 companies plus partners developing 333 radiation therapy drugs in ...

  • Industries : Therapy
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2014

RANKL Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Receptor activator of nuclear factor-kappa B ligand (RANKL) is a member of tumor necrosis factor (TNF) superfamily. It binds to Receptor activator of NF-kB (RANK) and plays a major role in the regulation ...

  • Industries : Drug Discovery and Development
Renal Cancer Drug Pipeline Update 2014

Renal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being ...

  • Industries : Drug and Medication
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2014

Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The Alpha6 Beta4 Integrin signaling pathway activates the PI 3-kinase/Akt, MAPK/NFkB and SMAD signaling modules. There are today 245 companies plus partners developing 385 Alpha6Beta4 integrin pathway ...

  • Industries : Drug Discovery and Development
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014

IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The IL-2 signaling pathway activates the Ras/MAPK, JAK/Stat and PI 3-kinase/Akt signaling modules. There are today 244 companies plus partners developing 370 IL-2 pathway targeting drugs in 1307 developmental ...

  • Industries : Drug Discovery and Development
IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2014

IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The IL-3 signaling pathway activates the JAK/STAT, MAPK and PI 3-kinase signaling modules. There are today 184 companies plus partners developing 261 IL-3 pathway targeting drugs in 971 developmental projects ...

  • Industries : Drug Discovery and Development
About 57 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Factor V Leiden in Coronary Artery Disease: High Factor V Clotti...
  • September 2014
    7 pages
  • Pathology  

    Myocardial Infa...  

  • United States  

View report >

Drug Market In The Us

September 2014

About 500 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.